SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of disaggregation of revenue

The following table presents our revenues disaggregated by sales channel:

	Three months ended
	March 31,
(in thousands)	2022		2021
Partner and Marketplace	$	3,812	$	3,178
Enterprise		3,094		2,610
Total revenues	$	6,906	$	5,788

Schedule of deferred revenue

The table below summarizes our deferred revenue as of March 31, 2022 and December 31, 2021:

	March 31,		December 31,
(in thousands)	2022		2021
Deferred revenue - current	$	7,500	$	7,068
Deferred revenue - noncurrent		10		5
Total deferred revenue	$	7,510	$	7,073

Schedule of commission cost

The table below summarizes the deferred commission costs as of March 31, 2022 and December 31, 2021:

	March 31,		December 31,
(in thousands)	2022		2021
Deferred costs - current	$	87	$	103
Deferred costs - noncurrent		28		34
Total deferred costs	$	115	$	137

Schedule of antidilutive securities outstanding excluded from computation of earnings Per share

Potentially dilutive securities outstanding as of March 31, 2022 and 2021, which were excluded from the computation of basic and diluted net loss per share for the years then ended, are as follows:

	March 31,
( in thousands)	2022	2021
Preferred stock (1)	—	266
Options	180	336
Warrants	29	64
Restricted stock units	1,072	995
Total	1,281	1,661

(1) Represents number of shares of common stock that are issuable upon conversion of outstanding shares of Series A Convertible Preferred Stock.

Summary the stock option, warrants, and RSUs activity

The following table summarizes the stock option, warrants, and RSUs activity for the three months ended March 31, 2022:

	Options	Warrants	RSUs
Outstanding at December 31, 2021	191,340	30,173	1,033,240
Granted	—	—	72,742
Exercised/Settled	—	—	(34,169)
Forfeited/Expired	(11,366)	(1,600)	—
Outstanding at March 31, 2022	179,974	28,573	1,071,813
Vested at March 31, 2022	86,708	28,573	344,377
Unvested at March 31, 2022	93,266	—	727,436

Schedule of stock-based compensation expense

	Three months ended March 31,
(in thousands)	2022		2021
Stock Options	$	107	$	149
RSUs		988		1,598
Unrestricted Shares of Common Stock		50		34
Total	$	1,145	$	1,781